1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Therapy Analysis & Statistics (p50)

Global Therapy Analysis & Statistics (p50)

1471-1500 of about 7300 reports

Sodium Dependent Noradrenaline Transporter (Norepinephrine Transporter or NET or Solute Carrier Family 6 Member 2 or SLC6A2) - Drugs in Development, 2021

  • $ 3000
  • April 2021
  • 145 pages

Sodium Dependent Noradrenaline Transporter (Norepinephrine Transporter or NET or Solute Carrier Family 6 Member 2 or SLC6A2) - Drugs in Development, 2021 Summary Sodium Dependent Noradrenaline Transporte ...

  • World
  • Hormone
  • Research And Development
  • Industry analysis

Microtubule Associated Protein Tau (Neurofibrillary Tangle Protein or Paired Helical Filament Tau or MAPT) - Drugs in Development, 2021

  • $ 3000
  • April 2021
  • 150 pages

Microtubule Associated Protein Tau (Neurofibrillary Tangle Protein or Paired Helical Filament Tau or MAPT) - Drugs in Development, 2021 Summary Microtubule Associated Protein Tau (Neurofibrillary Tangle ...

  • World
  • Research And Development
  • Drug Development
  • Industry analysis

Androgen Receptor (Dihydrotestosterone Receptor or Nuclear Receptor Subfamily 3 Group C Member 4 or DHTR or NR3C4 or AR) - Drugs in Development, 2021

  • $ 3000
  • April 2021
  • 160 pages

Androgen Receptor (Dihydrotestosterone Receptor or Nuclear Receptor Subfamily 3 Group C Member 4 or DHTR or NR3C4 or AR) - Drugs in Development, 2021 Summary Androgen Receptor (Dihydrotestosterone Recepto ...

  • World
  • Hormone
  • Industry analysis

Prostaglandin G/H Synthase 1 (Cyclooxygenase 1 or COX1 or Prostaglandin Endoperoxide Synthase 1 or Prostaglandin H2 Synthase 1 or PTGS1 or EC 1.14.99.1) - Drugs in Development, 2021

  • $ 3000
  • April 2021
  • 160 pages

Prostaglandin G/H Synthase 1 (Cyclooxygenase 1 or COX1 or Prostaglandin Endoperoxide Synthase 1 or Prostaglandin H2 Synthase 1 or PTGS1 or EC 1.14.99.1) - Drugs in Development, 2021 Summary Prostaglandin ...

  • World
  • Research And Development
  • Drug Development
  • Industry analysis

Glutamate Ionotropic Receptor NMDA Type Subunit (NMDAR or GRIN) - Drugs in Development, 2021

  • $ 3000
  • April 2021
  • 160 pages

Glutamate Ionotropic Receptor NMDA Type Subunit (NMDAR or GRIN) - Drugs in Development, 2021 Summary Glutamate Ionotropic Receptor NMDA Type Subunit (NMDAR or GRIN) - Drugs in Development, 2021 provides ...

  • World
  • Research And Development
  • Drug Development
  • Industry analysis

Kappa Type Opioid Receptor (KOR1 or OPRK or OPRK1) - Drugs in Development, 2021

  • $ 3000
  • April 2021
  • 170 pages

Kappa Type Opioid Receptor (KOR1 or OPRK or OPRK1) - Drugs in Development, 2021 Summary Kappa Type Opioid Receptor (KOR1 or OPRK or OPRK1) - Drugs in Development, 2021 provides in depth analysis on Kappa ...

  • World
  • Research And Development
  • Drug Development
  • Industry analysis

5-Hydroxytryptamine Receptor 2A (5 HT2A or Serotonin Receptor 2A or HTR2A) - Drugs in Development, 2021

  • $ 3000
  • April 2021
  • 170 pages

5-Hydroxytryptamine Receptor 2A (5 HT2A or Serotonin Receptor 2A or HTR2A) - Drugs in Development, 2021 Summary 5-Hydroxytryptamine Receptor 2A (5 HT2A or Serotonin Receptor 2A or HTR2A) - Drugs in Development, ...

  • World
  • Hormone
  • Research And Development
  • Industry analysis

Vascular Endothelial Growth Factor Receptor 2 (Fetal Liver Kinase 1 or Kinase Insert Domain Receptor or Protein Tyrosine Kinase Receptor flk 1 or VEGFR2 or CD309 or KDR or EC 2.7.10.1) - Drugs in Development, 2021

  • $ 3500
  • April 2021
  • 180 pages

Vascular Endothelial Growth Factor Receptor 2 (Fetal Liver Kinase 1 or Kinase Insert Domain Receptor or Protein Tyrosine Kinase Receptor flk 1 or VEGFR2 or CD309 or KDR or EC 2.7.10.1) - Drugs in Development, ...

  • World
  • Research And Development
  • Drug Development
  • Industry analysis

Vascular Endothelial Growth Factor (VEGF) - Drugs in Development, 2021

  • $ 3500
  • April 2021
  • 190 pages

Vascular Endothelial Growth Factor (VEGF) - Drugs in Development, 2021 Summary Vascular Endothelial Growth Factor (VEGF) - Drugs in Development, 2021 provides in depth analysis on Vascular Endothelial ...

  • World
  • Research And Development
  • Drug Development
  • Industry analysis

D2 Dopamine Receptor (Dopamine D2 Receptor or DRD2) - Drugs in Development, 2021

  • $ 3500
  • April 2021
  • 190 pages

D2 Dopamine Receptor (Dopamine D2 Receptor or DRD2) - Drugs in Development, 2021 Summary D2 Dopamine Receptor (Dopamine D2 Receptor or DRD2) - Drugs in Development, 2021 provides in depth analysis on ...

  • World
  • Cardiovascular Drug
  • Industry analysis

Vascular Endothelial Growth Factor A (Vascular Permeability Factor or VEGFA) - Drugs in Development, 2021

  • $ 3500
  • April 2021
  • 210 pages

Vascular Endothelial Growth Factor A (Vascular Permeability Factor or VEGFA) - Drugs in Development, 2021 Summary Vascular Endothelial Growth Factor A (Vascular Permeability Factor or VEGFA) - Drugs in ...

  • World
  • Research And Development
  • Drug Development
  • Industry analysis

Glucocorticoid Receptor (GR or Nuclear Receptor Subfamily 3 Group C Member 1 or NR3C1) - Drugs in Development, 2021

  • $ 3500
  • April 2021
  • 220 pages

Glucocorticoid Receptor (GR or Nuclear Receptor Subfamily 3 Group C Member 1 or NR3C1) - Drugs in Development, 2021 Summary Glucocorticoid Receptor (GR or Nuclear Receptor Subfamily 3 Group C Member 1 ...

  • World
  • Hormone
  • Research And Development
  • Industry analysis

Receptor Tyrosine Protein Kinase ERBB 2 - Drugs in Development, 2021

  • $ 3500
  • April 2021
  • 220 pages

Receptor Tyrosine Protein Kinase ERBB 2 (Metastatic Lymph Node Gene 19 Protein or Proto Oncogene Neu or Proto Oncogene C ErbB 2 or Tyrosine Kinase Type Cell Surface Receptor HER2 or p185erbB2 or HER2 o ...

  • World
  • Research And Development
  • Drug Development
  • Industry analysis

Cells Expressing Tumor Necrosis Factor Receptor Superfamily Member 17 (B Cell Maturation Antigen or CD269 or BCMA or TNFRSF17) - Drugs in Development, 2021

  • $ 3500
  • April 2021
  • 220 pages

Cells Expressing Tumor Necrosis Factor Receptor Superfamily Member 17 (B Cell Maturation Antigen or CD269 or BCMA or TNFRSF17) - Drugs in Development, 2021 Summary Cells Expressing Tumor Necrosis Facto ...

  • World
  • Immunotherapy
  • Monoclonal Antibody
  • Industry analysis

Insulin Receptor (IR or CD220 or INSR or EC 2.7.10.1) - Drugs in Development, 2021

  • $ 3500
  • April 2021
  • 230 pages

Insulin Receptor (IR or CD220 or INSR or EC 2.7.10.1) - Drugs in Development, 2021 Summary Insulin Receptor (IR or CD220 or INSR or EC 2.7.10.1) - Drugs in Development, 2021 provides in depth analysis ...

  • World
  • Insulin
  • Research And Development
  • Industry analysis

Tumor Necrosis Factor (Cachectin or TNF Alpha or Tumor Necrosis Factor Ligand Superfamily Member 2 or TNF a or TNF) - Drugs in Development, 2021

  • $ 3500
  • April 2021
  • 230 pages

Tumor Necrosis Factor (Cachectin or TNF Alpha or Tumor Necrosis Factor Ligand Superfamily Member 2 or TNF a or TNF) - Drugs in Development, 2021 Summary Tumor Necrosis Factor (Cachectin or TNF Alpha o ...

  • World
  • Monoclonal Antibody
  • Industry analysis

Prostaglandin G/H Synthase 2 (Cyclooxygenase 2 or COX2 or Prostaglandin Endoperoxide Synthase 2 or PHS II or Prostaglandin H2 Synthase 2 or PTGS2 or EC 1.14.99.1) - Drugs in Development, 2021

  • $ 3500
  • April 2021
  • 230 pages

Prostaglandin G/H Synthase 2 (Cyclooxygenase 2 or COX2 or Prostaglandin Endoperoxide Synthase 2 or PHS II or Prostaglandin H2 Synthase 2 or PTGS2 or EC 1.14.99.1) - Drugs in Development, 2021 Summary Prostaglandin ...

  • World
  • Research And Development
  • Drug Development
  • Industry analysis

Glucagon Like Peptide 1 Receptor (GLP1R) - Drugs in Development, 2021

  • $ 3500
  • April 2021
  • 270 pages

Glucagon Like Peptide 1 Receptor (GLP1R) - Drugs in Development, 2021 Summary Glucagon Like Peptide 1 Receptor (GLP1R) - Drugs in Development, 2021 provides in depth analysis on Glucagon Like Peptide ...

  • World
  • Research And Development
  • Drug Development
  • Industry analysis

Cells Expressing Receptor Tyrosine Protein Kinase ERBB 2 - Drugs in Development, 2021

  • $ 3500
  • April 2021
  • 325 pages

Cells Expressing Receptor Tyrosine Protein Kinase ERBB 2 (Metastatic Lymph Node Gene 19 Protein or Proto Oncogene Neu or Proto Oncogene C ErbB 2 or Tyrosine Kinase Type Cell Surface Receptor HER2 or p185erbB2 ...

  • World
  • Research And Development
  • Drug Development
  • Industry analysis

Mu Type Opioid Receptor (MOR1 or Mu Opiate Receptor or Mu Opioid Receptor or OPRM1) - Drugs in Development, 2021

  • $ 3500
  • April 2021
  • 325 pages

Mu Type Opioid Receptor (MOR1 or Mu Opiate Receptor or Mu Opioid Receptor or OPRM1) - Drugs in Development, 2021 Summary Mu Type Opioid Receptor (MOR1 or Mu Opiate Receptor or Mu Opioid Receptor or OPRM1) ...

  • World
  • Research And Development
  • Drug Development
  • Industry analysis

Tubulin - Drugs in Development, 2021

  • $ 3500
  • April 2021
  • 325 pages

Tubulin - Drugs in Development, 2021 Summary Tubulin - Drugs in Development, 2021 provides in depth analysis on Tubulin targeted pipeline therapeutics. The report provides comprehensive information complete ...

  • World
  • Research And Development
  • Drug Development
  • Industry analysis

Human SARS Coronavirus 2 Spike Glycoprotein (E2 or Peplomer Protein or S) - Drugs in Development, 2021

  • $ 3500
  • April 2021
  • 325 pages

Human SARS Coronavirus 2 Spike Glycoprotein (E2 or Peplomer Protein or S) - Drugs in Development, 2021 Summary Human SARS Coronavirus 2 Spike Glycoprotein (E2 or Peplomer Protein or S) - Drugs in Development, ...

  • World
  • Research And Development
  • Drug Development
  • Industry analysis

Epidermal Growth Factor Receptor (Proto Oncogene c ErbB 1 or Receptor Tyrosine Protein Kinase erbB 1 or HER1 or ERBB1 or EGFR or EC 2.7.10.1) - Drugs in Development, 2021

  • $ 3500
  • April 2021
  • 325 pages

Epidermal Growth Factor Receptor (Proto Oncogene c ErbB 1 or Receptor Tyrosine Protein Kinase erbB 1 or HER1 or ERBB1 or EGFR or EC 2.7.10.1) - Drugs in Development, 2021 Summary Epidermal Growth Facto ...

  • World
  • Research And Development
  • Drug Development
  • Industry analysis

Cannabinoid Receptor 2 (CB2 or CX5 or CNR2) - Drugs in Development, 2021

  • $ 3500
  • April 2021
  • 375 pages

Cannabinoid Receptor 2 (CB2 or CX5 or CNR2) - Drugs in Development, 2021 Summary Cannabinoid Receptor 2 (CB2 or CX5 or CNR2) - Drugs in Development, 2021 provides in depth analysis on Cannabinoid Recepto ...

  • World
  • Analgesic
  • Research And Development
  • Industry analysis

Cannabinoid Receptor 1 (CB1 or CANN6 or CNR1) - Drugs in Development, 2021

  • $ 3500
  • April 2021
  • 375 pages

Cannabinoid Receptor 1 (CB1 or CANN6 or CNR1) - Drugs in Development, 2021 Summary Cannabinoid Receptor 1 (CB1 or CANN6 or CNR1) - Drugs in Development, 2021 provides in depth analysis on Cannabinoid ...

  • World
  • Analgesic
  • Research And Development
  • Industry analysis

Drugs For Erectile Dysfunction Global Market Report 2021: COVID 19 Impact and Recovery to 2030

  • $ 5000
  • April 2021
  • 175 pages

Major players in the erectile dysfunction (ED) drugs market are Eli Lilly and Co., Pfizer, Bayer AG, Dong-A Pharmaceutical Co. Ltd and Vivus. The global drugs for erectile dysfunction market is expected ...

  • World
  • Europe
  • Dysfunction Drug
  • Industry analysis
  • Chronic Disease Prevalence

Veterinary Antibiotics Global Market Report 2021: COVID 19 Impact and Recovery to 2030

  • $ 5000
  • April 2021
  • 175 pages

Major players in the veterinary antibiotics market are Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Eli Lilly Company and Elanco. The global veterinary antibiotics market is expected to grow ...

  • United States
  • World
  • Anti-Infective
  • Industry analysis
  • Antibiotics Production

Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2021: COVID 19 Implications And Growth to 2030

  • $ 5000
  • April 2021
  • 175 pages

Major players in the insulin pens, syringes, pumps and injectors market are Novo Nordisk A/S (Denmark), Eli Lilly and Company, Medtronic plc (Ireland), Abbott, and Insulet Corporation (US). The global ...

  • World
  • United States
  • Insulin Delivery
  • Insulin
  • Industry analysis
  • Diabetes Prevalence

Anesthetics Global Market Report 2021: COVID 19 Implications And Growth to 2030

  • $ 5000
  • April 2021
  • 175 pages

Major players in the anesthetics market are Baxter, Abbott Laboratories, AstraZeneca, F. Hoffmann-La Roche AG, and B. Braun Melsungen AG The global anesthetics market is expected to decline from $8.57 ...

  • World
  • Anesthetics
  • Industry analysis

Monoclonal Antibodies (MAbS) Global Market Report 2021: COVID 19 Impact and Recovery to 2030

  • $ 5000
  • April 2021
  • 175 pages

Major players in the monoclonal antibodies (MABS) market are Johnson & Johnson, Merck, AbbVie, Amgen, and GlaxoSmithKline plc. The global monoclonal antibodies (mabs) market is expected to grow from $106.87 ...

  • World
  • India
  • Monoclonal Antibody
  • Industry analysis
  • Biologics Sales
  • Retail Revenue
About 14000 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Global Vaccine Market Trends

  • July 2021
  • 8 pages
  • Asia
  • China
  • Vaccine
  • Industry analysis
  • Vaccination Coverage
  • Health Provider Density

US Social Analysis July 2021

US Country Report July 2021


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on